reference/20092805

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20092805

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3479
issn	0732-183X 1527-7755
issueIdentifier	21
pageRange	3472-3479
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3472
bibliographicCitation	Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C, Hughes TP, Erben P, Van Tornout J, Stone RM. Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial. J Clin Oncol. 2009 Jul 20;27(21):3472–9. PMID: 19487385; PMCID: PMC4979080.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8279-7636 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e31814748fd8b81d2fb0411e4ab22fd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96f2a7f3db4ac2761355cabda5d75fe8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84d086c9914fe21bd153776f914353a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f72c58e096e5ec63a381ec8737d8e6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b9bdd1e3d520e17aa537df0ee21725b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_778e7af8bc4b38998f00d2aac022feba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8654f59608fa74a02f4e37ff57b22640 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_690a0634fdf80b94ec860ac9db2879d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e18ea6824aec98d54ab0f7f7a517190 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_278d6c6fedd1218491ab40491c80dfc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e67ff0d41a84d03c855b84ef92eb33c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6614c27331612dd1ce79265638fb74e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c32df5f6fdd84841203a0fa8f2531dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0dfb4bd73ea3d5dc4a63d5b901b709b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_915eeac1c9c7f289dbd10575f2e9b688 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35f5c0036287d25adc017242d8a10863 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_024e3f9841945fc7d3ffb8309d9083cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0626-0834 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86505157debd09e982c2be1b4a34c0f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa685d0599ebeee341aa7d3b3a724e3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2e73ca33ee15ba233980af7634aabb0
date	2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4979080 https://doi.org/10.1200/jco.2007.14.3339 https://pubmed.ncbi.nlm.nih.gov/19487385
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
discusses	http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0470497
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054198Q000188 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D013844Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000069439
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8900 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 77.